Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Gastric Cancer
Drug:
5-fluorouracil
(
Thymidylate synthase inhibitor
) +
irinotecan
(
Topoisomerase I inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
NCCN
Published date:
12/23/2020
Excerpt:
Gastric Cancer: Principles of systemic therapy…Other recommended regimens…Fluorouracil and Irinotecan
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.